首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   1340224篇
  免费   91355篇
  国内免费   3987篇
耳鼻咽喉   19146篇
儿科学   41004篇
妇产科学   36308篇
基础医学   191636篇
口腔科学   37938篇
临床医学   117542篇
内科学   257090篇
皮肤病学   30717篇
神经病学   101231篇
特种医学   52026篇
外国民族医学   283篇
外科学   203700篇
综合类   29727篇
现状与发展   2篇
一般理论   318篇
预防医学   87680篇
眼科学   32045篇
药学   108174篇
  8篇
中国医学   4637篇
肿瘤学   84354篇
  2021年   10117篇
  2019年   10242篇
  2018年   15063篇
  2017年   11753篇
  2016年   13134篇
  2015年   14798篇
  2014年   20133篇
  2013年   28510篇
  2012年   39096篇
  2011年   40873篇
  2010年   24209篇
  2009年   22685篇
  2008年   37472篇
  2007年   40339篇
  2006年   40623篇
  2005年   38261篇
  2004年   36357篇
  2003年   34828篇
  2002年   33529篇
  2001年   77058篇
  2000年   79014篇
  1999年   65550篇
  1998年   16198篇
  1997年   14064篇
  1996年   13620篇
  1995年   12743篇
  1994年   11465篇
  1993年   10814篇
  1992年   47975篇
  1991年   45629篇
  1990年   44691篇
  1989年   43032篇
  1988年   38953篇
  1987年   37783篇
  1986年   35494篇
  1985年   33170篇
  1984年   23783篇
  1983年   19884篇
  1982年   10813篇
  1979年   20899篇
  1978年   13863篇
  1977年   12406篇
  1976年   10533篇
  1975年   12070篇
  1974年   13987篇
  1973年   13486篇
  1972年   12871篇
  1971年   12197篇
  1970年   11149篇
  1969年   10794篇
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
1.
2.
Quality of Life Research - The COVID-19 pandemic might add to the stressors experienced by people living with rheumatic diseases. This study aimed to examine rheumatic patients’ functional...  相似文献   
3.
Molnár  B.  Aroca  S.  Dobos  A.  Orbán  K.  Szabó  J.  Windisch  P.  Stähli  A.  Sculean  A. 《Clinical oral investigations》2022,26(12):7135-7142
Clinical Oral Investigations - To evaluate t he long-term outcomes following treatment of RT 1 multiple adjacent gingival recessions (MAGR) using the modified coronally advanced tunnel (MCAT) with...  相似文献   
4.

Physical activity brings significant health benefits to middle-aged adults, although the research to date has been focused on late adulthood. This study aims to examine how ageing affects the self-reported and accelerometer-derived measures of physical activity levels in middle-aged adults. We employed the data recorded in the UK Biobank and analysed the physical activity levels of 2,998 participants (1381 men and 1617 women), based on self-completion questionnaire and accelerometry measurement of physical activity. We also assessed the musculoskeletal health of the participants using the dual-energy X-ray absorptiometry (DXA) measurements provided by the UK Biobank. Participants were categorised into three groups according to their age: group I younger middle-aged (40 to 49 years), group II older middle-aged (50 to 59 years), and group III oldest middle-aged (60 to 69 years). Self-reported physical activity level increased with age and was the highest in group III, followed by group II and I (P?<?0.05). On the contrary, physical activity measured by accelerometry decreased significantly with age from group I to III (P?<?0.05), and the same pertained to the measurements of musculoskeletal health (P?<?0.05). It was also shown that middle-aged adults mostly engaged in low and moderate intensity activities. The opposing trends of the self-reported and measured physical activity levels may suggest that middle-aged adults over-report their activity level as they age. They should be aware of the difference between their perceived and actual physical activity levels, and objective measures would be useful to prevent the decline in musculoskeletal health.

  相似文献   
5.
6.
7.
8.
9.
Inflammatory bowel disease (IBD) is a chronic disease that requires chronic treatment throughout the evolution of the disease, with a complex physiopathology that entails great challenges for the development of new and specific treatments for ulcerative colitis and Crohn´s disease. The anti-tumor necrosis factor alpha therapy has impacted the clinical course of IBD in those patients who do not respond to conventional treatment, so there is a need to develop new therapies and markers of treatment response. Various pathways involved in the development of the disease are known and the new therapies have focused on blocking the inflammatory process at the gastrointestinal level by oral, intravenous, subcutaneous, and topical route. All these new therapies can lead to more personalized treatments with higher success rates and fewer relapses. These treatments have not only focused on clinical remission, but also on achieving macroscopic changes at the endoscopic level and microscopic changes by achieving mucosal healing. These treatments are mainly based on modifying signaling pathways, by blocking receptors or ligands, reducing cell migration and maintaining the integrity of the epithelial barrier. Therefore, this review presents the efficacy and safety of the new treatments that are currently under study and the advances that have been made in this area in recent years.  相似文献   
10.
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号